Alert: The attendee list for ACS Spring 2026 is maintained solely by ACS and is proprietary to ACS. Distribution or other use of the list without express authorization by ACS is strictly prohibited.

The US Food and Drug Administration will now review Moderna’s new, messenger RNA–based flu vaccine after all, reversing course on a decision that rocked the biopharmaceutical industry last week.

Officials are going after metal-containing ingredients, including aluminum adjuvants. Here’s why vaccines need them ...

Our contributor recalls going from never having met a practicing chemist in his life to becoming a leader in science, and the biggest leadership lessons he’s taken with him ...

Keeping you up to date with the chemistry news that matters most. Published by the American Chemical Society.

After decades, scientists have finally pieced together the 23-step biosynthetic pathway to produce this cancer drug ...

The scientific community called the group’s July 2025 report ‘fundamentally incorrect.’ The EPA can use it to slash ...

But the EPA rescinded the endangerment finding anyway. In the final rule (PDF), the agency avoids any debate over the impact of GHG buildup in the atmosphere. Instead, it claims that it lacks the ...

The London biotech will develop small-molecule therapies to target a pathway some cancer cells use to lengthen their life ...

The inorganic chemical producer Searles Valley Minerals (SVM) is idling its soda ash and boric acid facilities in Trona and Argus, California, saying it cannot compete in international markets with ...

Andrew Oddy looks back on his career as Keeper of Conservation at the British Museum and the exposure test that bears his name ...

The administration wants to lean on allies, stockpiles, and targeted investments to compete with China, while experts warn of market distortion and call for innovative alternatives ...